Although CD4+ T-cell adoptive transfer alone had considerable therapeutic efficacy, the combination of CD4+ T-cell adoptive transfer and anti-PD-L1 exhibited additional effects in delaying tumor growth (Figure 5A). The gene discussed is CD4; the disease is neoplasm.